Ovarian Hyperstimulation clinical trials at UCSF
1 research study open to eligible people
open to eligible females ages 18-42
Randomized double blinded placebo-controlled trial to evaluate the impact of ovarian hyperstimulation on endometriosis-related symptoms and to evaluate the impact of letrozole use during ovarian hyperstimulation with respect to endometriosis-related symptoms, embryo/egg quality and quantity, and pregnancy rates.
San Francisco, California
Our lead scientists for Ovarian Hyperstimulation research studies include Marcelle I Cedars.